Completed PHASE4 INTERVENTIONAL 2-arm NCT03716934

CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial (craft)

Sponsor: Hospital San Carlos, Madrid

Interventions Antiarrhythmic drug Arctic Front Advance® balloon catheter Confirm RX heart monitor® (Abbott)

Updated 7 times since 2018 Last updated: Sep 9, 2025 Started: Jun 27, 2018 Primary completion: Apr 18, 2022 Completion: Apr 18, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Atrial Fibrillation and is currently completed. Hospital San Carlos, Madrid leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE4

Status: Unknown → Completed
Sep 2024 — Oct 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Mar 2022 — Feb 2024 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Jan 2021 — Mar 2022 [monthly]

Recruiting PHASE4
Nov 2018 — Jan 2021 [monthly]

Recruiting PHASE4

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital San Carlos, Madrid

Data source: Hospital San Carlos, Madrid

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain